Kumait Garoge
Overview
Explore the profile of Kumait Garoge including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
43
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chaftari A, Jordan M, Hachem R, Al Hamal Z, Jiang Y, Yousif A, et al.
Am J Infect Control
. 2016 Apr;
44(8):931-4.
PMID: 27112370
Background: The Centers for Disease Control and Prevention recently introduced the concept of mucosal barrier injury (MBI) in an attempt to recognize the possibility of a gastrointestinal source for certain...
2.
Raad I, Chaftari A, Zakhour R, Jordan M, Al Hamal Z, Jiang Y, et al.
Antimicrob Agents Chemother
. 2016 Mar;
60(6):3426-32.
PMID: 27001822
In cancer patients with long-term central venous catheters (CVC), removal and reinsertion of a new CVC at a different site might be difficult because of the unavailability of accessible vascular...
3.
Chaftari A, Hachem R, Jordan M, Garoge K, Hamal Z, El Zakhem A, et al.
Antimicrob Agents Chemother
. 2015 Oct;
60(1):239-44.
PMID: 26482312
Gram-positive bacterial infections are an important cause of morbidity and death among cancer patients, despite current therapy. In this case-control study, we evaluated the clinical outcomes and safety of telavancin...
4.
Chaftari A, Hachem R, Reitzel R, Jordan M, Jiang Y, Yousif A, et al.
PLoS One
. 2015 Jul;
10(7):e0130999.
PMID: 26148092
Procalcitonin (PCT) and Interleukin-6 (IL-6) have emerged as biomarkers for different inflammatory conditions. The purpose of the study was to evaluate the role of PCT and IL-6 as biomarkers of...
5.
Jamal M, Garoge K, Rosenblatt J, Hachem R, Raad I
Antimicrob Agents Chemother
. 2015 May;
59(8):4397-402.
PMID: 25941227
Continuous subcutaneous insulin infusion (CSII) using pumps is a widely used method for insulin therapy in patients with diabetes mellitus. Among the major factors that usually lead to the discontinuation...